BIOREM Reports Record Third Quarter Earnings of $ 2.7 Million and $0.16 EPS -Revenue Increases 48% over Same Period in Prior Year

  Three months ended 
September 30
Three months ended 
June 30
  2026 2025 2026
Revenue 16,631 11,253 15,689
Gross profit 5,644 3,166 4,912
Operating expenses 1,965 1,552 2,181
Ebitda 3,805 1,707 2,830
Net earnings 2,691 1,158 1,981
EPS – basic 0.158 0.072 0.122
EPS – fully diluted 0.148 0.062 0.105

Amounts are CAD thousands except per share data

The Company is reporting record third quarter revenues and earnings.

Revenues for the quarter totaled $16.6 milion, a $5.4 milion or 48% increase from revenues of $11.3 milion recorded during the third quarter of 2025. Year to date revenues also set records totaling $39.1 milion compared to $25.4 milion for the first nine months of 2025.

Earnings for the quarter were $2.7 milion representing $0.158 earnings per share, and year to date earnings were $6.6 milion or $0.29 per share.

New order bookings in the quarter totaled $15.1 milion bringing bookings for the nine months to $48.6 milion and maintaining the Company’s order backlog at $74.5 milion on September 30, 2026.

Gross profit in the quarter of $5.6 milion, represented 34% of revenue, compared to $4.9 milion and 31% of revenue in the second quarter of 2026. The increase in gross profit during the quarter was due to project mix and higher revenues in the quarter.

Operating expenses for the quarter were $2.0 milion, which was consistent with the same quarter in the previous year but $413,000 higher than the immediately preceding quarter due to increased variable sales expenses on the higher revenues recorded in the quarter.

“Our momentum from earlier in the year continued into the third quarter”, said Derek S. Webb, President and CEO. “Project execution continues to be strong, and the organization has responded effectively to the various chalenges that linger in the industry and greater economy. We have been able to maintain or improve our margins, and many projects are ahead of schedule.”

“Just as critical, our sales team continues to close strategic projects around the globe, with our backlog at near-historical levels. With many potential projects stil in the pipeline, management is excited at the future potential for the variety of new products and services being offered to our customer base.”

The Company’s cash position stood at $7.9 milion on September 30, 2026, compared with the $8.4 milion held on September 30, 2025. Working capital at the end of the quarter was $19.5 milion, up $7.8 milion from the $11.7 milion held on September 30, 2025 and up $2.6 milion from the $16.8 milion recorded at June 30, 2026.

For further information contact:
Derek S. Webb, President and Chief Executive Officer  
dwebb@biorem.biz
Tel:  (519) 767-9100 ext 240

Douglas Newman, Chief Financial Officer
dnewman@biorem.biz
Tel: (519) 767-9100 ext 287